500 great innovation projects competed for the Focus Innovation Award this year. We are very proud to be among the 25 nominees.

"Our Patients, our Mission" - this motto drives us and led to the development of the EXCOR® Active. For children with terminal heart failure, a mechanical Ventricular Assist Device (VAD) is often the only chance of survival until a donor heart is available. With the further development of the previous stationary system, Berlin Heart's new mobile drive EXCOR® Active offers children more mobility and independence to play, learn and laugh despite severe heart disease.

More information: www.linkedin.com/posts/focus-magazin_focusinnovationspreis-innovationen-ideendiebewegen-activity-6726907862041292800-jlaF/

EXCOR® Active is not FDA approved.